Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Cancer|May 25, 2005
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trialCharles L Loprinzi, Ralph Levitt, Debra L Barton, et al.
Clinical Breast Cancer|December 31, 2005
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252Edith A Perez, Vera J Suman, Kendrith M Rowland, et al.
Gastroenterology|November 26, 2008
High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assayHongzhi Zou, William R Taylor, Jonathan J Harrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)Deirdre R Pachman, Rui Qin, Drew K Seisler, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2010
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CADebra L Barton, Edward J Wos, Rui Qin, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4Robert C Miller, David J Schwartz, Jeff A Sloan, et al.
The Journal of Supportive Oncology|March 15, 2011
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)Debra L Barton, Pamela J Atherton, Brent A Bauer, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1996
Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicityM S Williams, M Burk, C L Loprinzi, et al.
Breast (Edinburgh, Scotland)|March 21, 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot studyTeresa M Salgado, Jin Liu, Holly L Reed, et al.
Pageof 37